HPV16 DNA in Oral Rinses at Oropharyngeal Cancer Diagnosis
But rarely seen after treatment; correlations for persistent HPV16 DNA with worse survival
2015 MOC Program Expected to Cost $5.7 Billion Over 10 Years
Time costs account for 90 percent of maintenance of certification costs, estimated at $5.1 billion
RAPID Score Validated for Prognosis of Pleural Infections
Recently developed score is valid for identifying mortality risk through five years in diverse cohort
Novel Microendoscope Ups Accuracy of Esophageal Screening
Low-cost HRME ups accuracy of Lugol's chromoendoscopy for esophageal cancer
New Rx for Myeloid Malignancies Moves to Phase II Clinical Trials
Phase I trial involving 47 patients identified maximum tolerated dose of 400 mg once daily
Not Resecting Ideal Candidates Ups Mortality in Liver Cancer
For nonideal candidates, resection linked to improved outcomes versus some alternatives
ASCO Calls for Cancer Trials to Include More Seniors
Older adults react differently to treatment, oncology group notes
Patients Report Improved Care Access, Better Health With ACA
Gains seen in how many adults have insurance and a doctor, and say they are in better health
Delays Noted in the Reporting of Serious Patient Harms to FDA
Analysis found roughly 10 percent of cases were filed after 15-day deadline passed
35% of Colorectal Cancers in Patients Age ≤35 Are Genetic
Study authors recommend that people diagnosed before age 35 get tested
